Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-03-25 | Derica W. Rice Director Since: 2020 Age: 56 Board Committees • Audit Committee (Chair) • Compensation and Management Development Committee Other Public Boards • Target Corporation • The Walt Disney Company Experience • Executive Vice President of CVS Health and President, Pharmacy Benefits Business of CVS Caremark (2018-2020) • Executive Vice President of Global Services (2010-2017) and Chief Financial Officer (2006-2017) of Eli Lilly and Company • Vice President and Controller (2003-2006) and various executive positions at Eli Lilly and Company (1990-2005) Key Skills and Experience • Public Company CEO / CFO •Financial • Healthcare • Risk Management Other • Director of Center for Leadership Development |
| 2022-03-24 | Experience: • Executive Vice President of CVS Health and President, Pharmacy Benefits Business of CVS Caremark (2018-2020) • Executive Vice President of Global Services (2010-2017) and Chief Financial Officer (2006-2017) of Eli Lilly and Company |
| 2023-03-23 | Derica W. Rice Director Since: 2020 Age: 58 Board Committees • Audit Committee (Chair) • Compensation and Management Development Committee Other Public Company Boards • Target Corporation • The Walt Disney Company • The Carlyle Group |
| 2024-03-28 | Derica W. Rice Chair of the Audit Committee DIRECTOR SINCE: 2020 AGE: 59 BOARD COMMITTEES Audit Committee (Chair), Compensation and Management Development Committee ... Director Compensation Table shows $375,000 total compensation. |
| 2025-03-26 | Derica W. Rice Chair of the Audit Committee Director Since: 2020 Age: 60 Board Committees • Audit Committee (Chair) • Compensation and Management Development Committee |
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-27 | Derica W. Rice is Executive Vice President, Global Services and Chief Financial Officer of Eli Lilly and Company, a pharmaceutical company, positions he has held since January 2010 and May 2006, respectively. From May 2006 to December 2009, he served as Eli Lilly’s Senior Vice President and Chief Financial Officer. |
| 2016-04-25 | Derica W. Rice is Executive Vice President, Global Services and CFO of Eli Lilly and Company... Committees: Audit and Finance (Chair), Risk and Compliance... Director Compensation Table: Derica W. Rice $303,777 total compensation. |
| 2017-05-01 | Derica W. Rice is Executive Vice President, Global Services & Chief Financial Officer of Eli Lilly and Company, a pharmaceutical company, positions he has held since January 2010 and May 2006, respectively. Qualifications Mr. Rice’s career with Eli Lilly has provided him with substantial experience in managing worldwide financial operations. His expertise gives the Board additional skills in the areas of financial oversight, risk management and the alignment of financial and strategic initiatives. |
| 2021-04-26 | Derica W. Rice is the former Executive Vice President of CVS Health Corporation, a provider of health services and plans in the United States, and former President of CVS Caremark, the pharmacy benefits management business of CVS Health Corporation. He served in those positions from March 2018 to February 2020. Mr. Rice previously held several other executive level positions over nearly three decades with Eli Lilly and Company, a pharmaceutical company, including Executive Vice President, Global Services from January 2010 through December 2017 and Chief Financial Officer from May 2006 through December 2017. He also previously served on Target Corporation’s board of directors from September 2007 to January 2018. Qualifications Mr. Rice’s career has provided him with practical knowledge of executive management of complex, worldwide businesses, and extensive experience in a wide range of financial and accounting matters including management of worldwide financial operations, financial oversight, risk management, and the alignment of financial and strategic initiatives. Other public company boards Derica W. Rice Age 56 Director since 2020 Independent Committees Audit & Finance Governance Current Bristol-Myers Squibb The Carlyle Group Inc. The Walt Disney Company Within past five years Target Corporation Director compensation table Derica W. Rice Fees earned or paid in cash $57,500 Stock awards $140,199 Option awards $0 Total $197,699 |
| 2022-04-25 | Derica W. Rice is the former Executive Vice President of CVS Health Corporation, a provider of health services and plans in the United States, and former President of CVS Caremark, the pharmacy benefits management business of CVS Health Corporation. He served in those positions from March 2018 to February 2020. Mr. Rice previously held several other executive level positions over nearly three decades with Eli Lilly and Company, a pharmaceutical company, including Executive Vice President, Global Services from January 2010 through December 2017 and Chief Financial Officer from May 2006 through December 2017. He also previously served on Target Corporation’s Board of Directors from September 2007 to January 2018. Committees: Audit & Risk, Infrastructure & Finance. Director compensation total: $295,144. |
| 2023-05-01 | Derica W. Rice is the former Executive Vice President of CVS Health Corporation, a provider of health services and plans in the United States, and former President of CVS Caremark, the pharmacy benefits management business of CVS Health Corporation. ... Mr. Rice provides the Board with retail industry experience, senior leadership, human capital management, capital deployment, global supply chain, information security / data privacy, financial management, risk management, reputation management, and ESG skills developed over his more than 30 years of service with escalating levels of responsibility across finance and operations at Eli Lily and CVS. ... Committees: Audit & Risk, Infrastructure & Finance. Director compensation table: Derica W. Rice Fees earned or paid in cash: $0, Stock awards: $310,071, Total: $310,071. |
| 2024-04-29 | Derica W. Rice is the former Executive Vice President of CVS Health Corporation. |
Data sourced from SEC filings. Last updated: 2025-07-01